Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 706
Selected: 0
NCT IDTitle
NCT00338273A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
NCT00317356A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis
NCT01262651Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer
NCT04174170Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
NCT00101569Aripiprazole Oral Acceptability Trial
NCT01360866Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
NCT01424566A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer
NCT01131351Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
NCT01378650A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus
NCT00955812STAT3 Inhibitor for Solid Tumors
NCT02220712A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia
NCT00362271Aripiprazole and Effexor XR Drug Interaction Study
NCT03376763MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
NCT01141387Outcomes in MEasurement-Based Treatment
NCT00272454Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
NCT01475370Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)
NCT05542264A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
NCT01184807Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors
NCT03324581The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
NCT04241965A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
NCT00763490Trial Of Double Umbilical Cord Blood Transplantation
NCT00809276Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY
NCT04049825A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL
NCT00823849Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
NCT00524498A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma
NCT04362007A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma
NCT03828201Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
NCT02013622Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
NCT02758067Comparison of the Effectiveness of Brexpiprazole With That of Risperidone
NCT00606229A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT00413777Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT00484471ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
NCT01710709Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT01406574Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma
NCT03303105Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
NCT05248646Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT01895322Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
NCT03420222Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder
NCT07253441A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels
NCT01129882An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
NCT04100096A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
NCT03902574Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg
NCT01418339Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT01590901Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
NCT04786730A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
NCT05279313A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
NCT04355117A Safety Evaluation Trial of TEV-48125 Self-administered in Migraine Patients
NCT00361790Aripiprazole and Lexapro Drug Interaction Study
NCT01987960Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)